Capecitabine in Combination With Aromatase Inhibitor Versus Aromatase Inhibitors, in Hormonal Receptor Positive Recurrent or Metastatic Breast Cancer Patients, Randomized Controlled Study
Clinical trial NCT04012918 · UNKNOWN
Trial details
- NCT number
- NCT04012918
- Sponsor
- Ain Shams University
- Status
- UNKNOWN
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2018-08-30
- Primary completion
- 2020-08-01
- Enrollment
- 124
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.